Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study

The MabThera and Involved field Radiotherapy study investigated efficacy and safety of involved field (IF) radiotherapy in combination with the anti-CD20 antibody Rituximab for early-stage follicular lymphoma (FL) in a prospective, single-arm multicenter phase 2 design. Eighty-five stage I–II FL pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Herfarth, Klaus, Borchmann, Peter, Schnaidt, Sven, Hohloch, Karin, Budach, Volker, Engelhard, Marianne, Viardot, Andreas, Engenhart-Cabillic, Rita, Keller, Ulrich, Reinartz, Gabriele, Eich, Hans-Theodor, Witzens-Harig, Mathias, Hess, Clemens F., Dörken, Bernd, Dürig, Jan, Wiegel, Thomas, Hiddemann, Wolfgang, Hoster, Eva, Pott, Christiane, Dreyling, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745956/
https://www.ncbi.nlm.nih.gov/pubmed/31723798
http://dx.doi.org/10.1097/HS9.0000000000000160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745956/
https://www.ncbi.nlm.nih.gov/pubmed/31723798
http://dx.doi.org/10.1097/HS9.0000000000000160

Ejemplares similares